A. Wotherspoon

615 total citations
19 papers, 429 citations indexed

About

A. Wotherspoon is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Wotherspoon has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Wotherspoon's work include Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). A. Wotherspoon is often cited by papers focused on Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). A. Wotherspoon collaborates with scholars based in United Kingdom, Canada and Japan. A. Wotherspoon's co-authors include David Cunningham, A. Norman, Francesca Negri, Geoff Chong, Paul J. Ross, Gina Brown, Diana Tait, Ian Chau, Vincenzo Formica and Geoffrey Chong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

A. Wotherspoon

19 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wotherspoon United Kingdom 11 297 210 115 87 78 19 429
Prasanna Ghimire Nepal 9 144 0.5× 192 0.9× 249 2.2× 148 1.7× 72 0.9× 34 491
Robert McMillan United States 14 222 0.7× 245 1.2× 115 1.0× 281 3.2× 78 1.0× 29 723
Hakan Postacı Türkiye 13 136 0.5× 145 0.7× 100 0.9× 123 1.4× 100 1.3× 45 460
Kazuhiro Tasaki Japan 11 159 0.5× 117 0.6× 70 0.6× 114 1.3× 83 1.1× 31 428
Maylee Hsu United States 11 196 0.7× 322 1.5× 41 0.4× 70 0.8× 228 2.9× 17 565
Randolph M. Steinhagen United States 15 247 0.8× 506 2.4× 57 0.5× 62 0.7× 130 1.7× 38 688
Alison R. Huppmann United States 12 110 0.4× 95 0.5× 141 1.2× 64 0.7× 65 0.8× 27 351
Dipti M. Karamchandani United States 12 185 0.6× 178 0.8× 60 0.5× 104 1.2× 80 1.0× 58 466
Neelaiah Siddaraju India 11 119 0.4× 168 0.8× 60 0.5× 93 1.1× 89 1.1× 81 405
Varsha Manucha United States 11 179 0.6× 186 0.9× 56 0.5× 124 1.4× 105 1.3× 52 447

Countries citing papers authored by A. Wotherspoon

Since Specialization
Citations

This map shows the geographic impact of A. Wotherspoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wotherspoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wotherspoon more than expected).

Fields of papers citing papers by A. Wotherspoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wotherspoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wotherspoon. The network helps show where A. Wotherspoon may publish in the future.

Co-authorship network of co-authors of A. Wotherspoon

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wotherspoon. A scholar is included among the top collaborators of A. Wotherspoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wotherspoon. A. Wotherspoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Davidson, Martin, Sonia Mansukhani, Naureen Starling, et al.. (2019). Perioperative FLOT + anti-PD-L1 avelumab (FLOT-A) chemo-immunotherapy in resectable oesophagogastric adenocarcinoma (OGA): Safety and biomarker data from the ICONIC trial safety run-in. Annals of Oncology. 30. v254–v254. 1 indexed citations
2.
Siddiqui, M., Irıs D. Nagtegaal, Nicholas P. West, et al.. (2018). Agreement between histopathologic regression and MRI Tumour Regression (mrTRG) scales used to assess response for rectal cancers. International Journal of Surgery. 55. S43–S44. 1 indexed citations
3.
Balyasnikova, Svetlana, Diana Tait, A. Wotherspoon, et al.. (2017). The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery. Colorectal Disease. 19(2). 139–147. 20 indexed citations
4.
Brown, Gina, Richard J. Heald, Sue Chua, et al.. (2011). Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: A phase II multicenter study in the United Kingdom.. Journal of Clinical Oncology. 29(4_suppl). 489–489. 18 indexed citations
5.
Anoop, Parameswaran, et al.. (2010). Synchronous Mantle Cell Lymphoma, Chronic Lymphocytic Leukaemia and Melanoma in a Single Lymph Node. Acta Haematologica. 123(3). 194–196. 16 indexed citations
6.
Patel, Ketan, et al.. (2010). Gastric actinomycosis: an rare endoscopic diagnosis. Endoscopy. 42(S 02). E218–E219. 3 indexed citations
7.
Chong, Irene, Gina Brown, R J Heald, et al.. (2010). A multicenter phase II clinical study evaluating the deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (CRT).. Journal of Clinical Oncology. 28(15_suppl). TPS191–TPS191. 7 indexed citations
9.
Aarvold, Alexander, et al.. (2007). Osteosarcoma metastasising to the duodenum and pancreas. Journal of Bone and Joint Surgery - British Volume. 89-B(4). 542–544. 15 indexed citations
10.
Formica, Vincenzo, A. Wotherspoon, David Cunningham, et al.. (2007). The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract. British Journal of Cancer. 96(8). 1178–1182. 44 indexed citations
11.
Gil, Veronica, Louise Howell, Jenny Yeung, et al.. (2007). Ectopic Expression of HDAC9 in Murine Lymphoid System Leads to Altered Lymphocyte Numbers and Proliferation as Well as Predisposition to Tumorigenesis.. Blood. 110(11). 376–376. 1 indexed citations
12.
Burton, Sarah, Gina Brown, I. R. Daniels, et al.. (2006). MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: Treatment with radiotherapy and chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 65(2). 445–451. 49 indexed citations
13.
Osuji, Nnenna, Estella Matutes, Alison Morilla, et al.. (2005). Prolonged treatment response in aggressive natural killer cell leukemia. Leukemia & lymphoma. 46(5). 757–763. 3 indexed citations
14.
Negri, Francesca, A. Wotherspoon, David Cunningham, et al.. (2005). Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Annals of Oncology. 16(8). 1305–1310. 123 indexed citations
16.
Waters, Justin S., Ian Chau, A. R. Norman, et al.. (2004). Gemcitabine (GEM), cisplatin (P) and methylprednisolone: A salvage regimen in relapsed Hodgkin's disease and non-Hodgkin's lymphoma. Journal of Clinical Oncology. 22(14_suppl). 6589–6589. 1 indexed citations
17.
Chau, Ian, Muireann Kelleher, David Cunningham, et al.. (2003). Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. British Journal of Cancer. 88(3). 354–361. 74 indexed citations
18.
Pinkerton, CR, Ian Hann, Claire Weston, et al.. (2002). Immunodeficiency‐related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry. British Journal of Haematology. 118(2). 456–461. 23 indexed citations
19.
Wotherspoon, A., et al.. (1974). Congenital pulmonary lymphangiectasis. Pediatric Radiology. 2(4). 235–239. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026